glucophage xr 500 mg ilgstošās darbības tabletes
merck sante s.a.s., france - metformīna hidrohlorīds - ilgstošās darbības tablete - 500 mg
metfogamma 850 mg apvalkotās tabletes
wörwag pharma gmbh & co.kg, germany - metformīna hidrohlorīds - apvalkotā tablete - 850 mg
metfogamma 500 mg apvalkotās tabletes
wörwag pharma gmbh & co.kg, germany - metformīna hidrohlorīds - apvalkotā tablete - 500 mg
metformin accord 500 mg apvalkotās tabletes
accord healthcare b.v., netherlands - metformīna hidrohlorīds - apvalkotā tablete - 500 mg
metformin accord 850 mg apvalkotās tabletes
accord healthcare b.v., netherlands - metformīna hidrohlorīds - apvalkotā tablete - 850 mg
metformin accord 1000 mg apvalkotās tabletes
accord healthcare b.v., netherlands - metformīna hidrohlorīds - apvalkotā tablete - 1000 mg
metformin zentiva 500 mg apvalkotās tabletes
zentiva, k.s., czech republic - metformīna hidrohlorīds - apvalkotā tablete - 500 mg
metformin zentiva 850 mg apvalkotās tabletes
zentiva, k.s., czech republic - metformīna hidrohlorīds - apvalkotā tablete - 850 mg
metformin zentiva 1000 mg apvalkotās tabletes
zentiva, k.s., czech republic - metformīna hidrohlorīds - apvalkotā tablete - 1000 mg
eucreas
novartis europharm limited - vildagliptin, metformīns hidrohlorīds - cukura diabēts, 2. tips - drugs used in diabetes, combinations of oral blood glucose lowering drugs - eucreas is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control.